Cite
HARVARD Citation
Zanchi, A. et al. (2020). Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial. Journal of the American Heart Association. 9 (13), p. n/a. [Online].